EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics

Luis Michea, Thomas T Kim, Brian Hutchinson, Luis Toro, Maria C Escobar, Soumava Basu, Muhammad Jami Husain, Andrew E Moran, Pedro Ordunez, Deliana Kostova, Chile HEARTS Collaborative Group

Value in Health · 2025

DOI: 10.1016/j.jval.2025.06.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2025. Verfasst von Luis Michea und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences (ICBM), Facultad de Medicina, University of Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Hypertension, Primary Health Care, Antihypertensive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0). Gefördert von: Pan American Health Organization, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In 2016, Chile implemented a pilot project in 2 Santiago-area family health centers aimed at improving hypertension control using the HEARTS framework for cardiovascular disease prevention. The core intervention replaced nonstandardized, single-medication regimens with standardized treatment using fixed-dose combination pills. Although prior studies demonstrate improved blood pressure control with fixed-dose combination pills, evidence on cost-effectiveness is essential for scalability. METHODS: A 10-year outcomes-based Markov model was used to assess the benefits and costs of the HEARTS approach versus usual care from a societal perspective. Incremental program costs were estimated via activity-based costing, and incremental benefits from reductions in acute CVD events. The cost-effectiveness was quantified using incremental benefit-cost ratios and incremental cost per averted disability-adjusted life-year. RESULTS: Although the HEARTS approach led to higher initial medication costs, averted CVD events generated net savings over time. The incremental benefit-cost ratio was estimated to exceed 1 by year 2 and reached 7.8 by year 10, showing that incremental benefits would exceed costs at an increasing rate over time. The cost per disability-adjusted life-year averted in model year 10 was approximately $2171, demonstrating high cost-effectiveness compared with the per-capita gross domestic product threshold. CONCLUSIONS: The HEARTS approach in Chile, which uses a standardized hypertension treatment protocol with fixed-dose combination pills, was estimated to be highly cost-effective compared with usual care. It generates substantial net savings over time from estimated reductions in the incidence of acute cardiovascular disease events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionPrimary Health CareAntihypertensive AgentsHumansChileCost-Benefit AnalysisMarkov ChainsDrug CombinationsQuality-Adjusted Life YearsMiddle AgedMaleFemalePilot ProjectsCardiovascular DiseasesAged

Stichwörter der Autor:innen

HEARTSMarkov modelcost and benefitcost-effectivenesshypertension

Substanzen

Antihypertensive AgentsDrug Combinations

Autor:innen und Institutionen

  • Institute of Biomedical Sciences (ICBM), Facultad de Medicina, University of Chile, Santiago, Chile.
  • Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ufg8@cdc.gov.
  • RTI International, Seattle, WA, USA.
  • Division of Nephrology, Department of Medicine, Centro de Investigación Clínica Avanzada, Hospital Clínico Universidad de Chile, Santiago, Chile.
  • Pan American Health Organization, Santiago, Chile.
  • Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Förderung

  • Pan American Health Organization
  • Centers for Disease Control and Prevention

Zitieren

APA

Michea, L., Kim, T. T., Hutchinson, B., Toro, L., Escobar, M. C., Basu, S., Husain, M. J., Moran, A. E., Ordunez, P., Kostova, D., & Chile HEARTS Collaborative Group (2025). Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics. Value in Health. https://doi.org/10.1016/j.jval.2025.06.012

Vancouver

Michea L, Kim TT, Hutchinson B, Toro L, Escobar MC, Basu S, et al. Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics. Value in Health. 2025. doi:10.1016/j.jval.2025.06.012

BibTeX
@article{Michea2025,
  author = {Michea, Luis and Kim, Thomas T and Hutchinson, Brian and Toro, Luis and Escobar, Maria C and Basu, Soumava and Husain, Muhammad Jami and Moran, Andrew E and Ordunez, Pedro and Kostova, Deliana and Chile HEARTS Collaborative Group, Chile HEARTS Collaborative Group},
  title = {Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics},
  journal = {Value in Health},
  year = {2025},
  doi = {10.1016/j.jval.2025.06.012}
}
Kostenlos starten →